Minimally invasive versus open surgery in uterine serous carcinoma: impact on recurrence and survival in a multicenter cohort
- PMID: 41142621
- PMCID: PMC12549236
- DOI: 10.3389/fonc.2025.1665803
Minimally invasive versus open surgery in uterine serous carcinoma: impact on recurrence and survival in a multicenter cohort
Abstract
Background: Uterine serous carcinoma (USC) is a highly aggressive subtype of endometrial cancer, characterized by high recurrence rates and poor prognosis. While minimally invasive surgery (MIS) is commonly used in endometrial cancer treatment, its oncologic safety in high-risk USC remains unclear. This study aimed to compare survival outcomes between MIS and open surgery in patients with USC.
Methods: In this multicenter retrospective cohort study, 176 patients with USC who underwent primary surgical treatment were included (MIS: 53 [30.1%], open: 123 [69.9%]). Kaplan-Meier analysis was used to estimate overall survival (OS) and progression-free survival (PFS), while Cox regression identified independent prognostic factors.
Results: The median follow-up was 78 months (95% CI: 68.3-87.7). Patients in the MIS group experienced a higher recurrence rate (49.1% vs. 31.7%) and lower 5-year PFS (49.7% vs. 68.3%, P = 0.017), although 5-year OS was comparable between groups (69.7% vs. 77.4%, P = 0.219). Multivariate analysis confirmed that MIS as an independent predictor of poorer PFS (HR = 2.29, 95% CI: 1.31-4.01, P = 0.004). In contrast, adjuvant therapy significantly improved PFS (HR = 0.28, 95% CI: 0.13-0.60, P = 0.001). Hypertension was also associated with decreased OS (HR = 2.06, 95% CI: 1.11-3.81, P = 0.022).
Conclusions: MIS may be associated with an increased risk of recurrence and reduced PFS in USC patients, while adjuvant therapy remains critical for improving survival outcomes.
Keywords: minimally invasive surgery; open surgery; overall survival; progression-free survival; surgical outcomes; uterine serous carcinoma.
Copyright © 2025 Fang, Chen, Yang, Lin, Lin, Lin and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- McGunigal M, Liu J, Kalir T, Chadha M, Gupta V. Survival differences among uterine papillary serous, clear cell and grade 3 endometrioid adenocarcinoma endometrial cancers: A national cancer database analysis. Int J Gynecol Cancer. (2017) 27:85–92. doi: 10.1097/IGC.0000000000000844, PMID: - DOI - PubMed
-
- Network NCCN . Uterine Neoplasms. In: NCCN Clinical Practice Guidelines in Oncology, vol. 3.2025. Plymouth Meeting, PA: National Comprehensive Cancer Network (NCCN). (2025). Available online at: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1473 (Accessed September 30, 2025).
-
- Janda M, Gebski V, Davies LC, Forder P, Brand A, Hogg R, et al. Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer: A randomized clinical trial. JAMA. (2017) 317:1224–33. doi: 10.1001/jama.2017.2068, PMID: - DOI - PubMed
LinkOut - more resources
Full Text Sources
